Michael Bishop to Historically Controlled Study
This is a "connection" page, showing publications Michael Bishop has written about Historically Controlled Study.
Connection Strength
0.051
-
Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study. J Hematol Oncol. 2022 12 10; 15(1):170.
Score: 0.051